Search Results

Containing any of the words

Only of the type

SFDA Alerts From Using Certain Lots of ‘ 1DAY ACUVUE® MOIST®’ Contact Lens for astigmatism, produced by ‘Johnson & Johnson Vision Care’ Awareness Article

Through the Conference Sessions & Accompanying Exhibition:SFDA Participates in the 2nd. National e-government Conference ”Yesser” News

Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. Drug Clinical Trial

Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia Drug Clinical Trial

SAUDI ARABIA – A DISEASE REGISTRY STUDY TO PROSPECTIVELY OBSERVE TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH HER2-POSITIVE UNRESECTABLE LOCALLY ADVANCED OR METASTATIC BREAST CANCER Drug Clinical Trial

Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. Drug Clinical Trial

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen Drug Clinical Trial

The Effect of Empagliflozin (SGLT2 Inhibitor) in Pulmonary Arterial Hypertension: A Single Arm Prospective Interventional Study Drug Clinical Trial

(SG-1907-73-H) Hemodialysis Venous Catheter Components May Disengage during Routine Use, Quickly Causing Patient Harm or Death Medical Report

The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus Drug Clinical Trial